All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
| Tue 1982-02-16? to Wed 2026-01-21 |
YTD
Return |
TRR
Price |
||||
|---|---|---|---|---|---|---|
| TEVA × |
+0.51%
2026-01-21 |
24.99 TRR
2026-01-21 |
||||
| Teva Pharma Industries Ltd ADR NYSE Common Stock | ||||||
| Tue 1982-02-16? to Wed 2026-01-21 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| TEVA × |
+2,398.81%
+7.60%/yr |
+10.85%/yr
(R2=0.576) |
||||
| Teva Pharma Industries Ltd ADR NYSE Common Stock | ||||||
| Tue 1982-02-16? to Wed 2026-01-21 |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| TEVA × |
$10,000.00
1982-02-16 |
$249,880.67
2026-01-21 |
||||
| Teva Pharma Industries Ltd ADR NYSE Common Stock | ||||||
| Year | TEVA |
|---|---|
| 2026 (YTD) | +0.51% |
| 2025 | +37.91% |
| 2024 | +105.25% |
| 2023 | +10.72% |
| 2022 | +6.95% |
| 2021 | −22.44% |
| 2020 | −2.91% |
| 2019 | −37.85% |
| 2018 | −20.13% |
| 2017 | −47.08% |
| 2016 | −44.35% |
| 2015 | +15.85% |
| 2014 | +46.26% |
| 2013 | +9.27% |
| 2012 | −6.75% |
| 2011 | −23.32% |
| 2010 | −7.28% |
| 2009 | +30.10% |
| 2008 | −7.45% |
| 2007 | +45.03% |
| 2006 | −28.90% |
| 2005 | +40.43% |
| 2004 | +2.70% |
| 2003 | +45.18% |
| 2002 | +23.04% |
| 2001 | −16.78% |
| 2000 | +100.00% |
| 1999 | +72.41% |
| 1998 | −14.82% |
| 1997 | −7.01% |
| 1996 | +5.95% |
| 1995 | +89.41% |
| 1994 | −20.73% |
| 1993 | +34.70% |
| 1992 | +127.36% |
| 1991 | +60.73% |
| 1990 | −6.55% |
| 1989 | +65.77% |
| 1988 | +6.07% |
| 1987 | −3.96% |
| 1986 | +129.73% |
| 1985 | +198.75% |
| 1984 | −34.83% |
| 1983 | −74.41% |
| 1982 | −46.62% |
| Tue 1982-02-16? to Wed 2026-01-21 |
Current
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| TEVA × | −65.52% |
−93.82%
1984-11-19 |
||||
| Teva Pharma Industries Ltd ADR NYSE Common Stock | ||||||